Sagent Pharmaceuticals Inc. – Sagent Pharmaceuticals, Inc. Separation Agreement and Release of Claims (April 6th, 2016)
This Separation Agreement and Release of Claims (the "Separation Agreement") is by and between Michael Logerfo (the "Executive") and Sagent Pharmaceuticals, Inc. ("Sagent" or the "Company").
Sagent Pharmaceuticals Inc. – Share Purchase Agreement (February 9th, 2016)
1. SAGENT PHARMACEUTICALS, INC. (the "Selling Shareholder"), a company duly incorporated and validly existing under the laws of Delaware, having its business address at 1901 North Roselle Road, Suite 700, Schaumburg, IL60195; and
Sagent Pharmaceuticals Inc. – Via Email December 2, 2015 Dear Michael, (December 2nd, 2015)
This letter (the Letter Amendment) amends your employment agreement effective as of December 2, 2015 (the Amendment Effective Date) with Sagent Pharmaceuticals Inc. (the Company) dated as of January 20, 2011, and amended as of April 15, 2015 (the Employment Agreement). All capitalized terms not defined herein shall have the meaning attributed to them in the Employment Agreement.
Sagent Pharmaceuticals Inc. – Employment Agreement (November 3rd, 2015)
This EMPLOYMENT AGREEMENT (Agreement) is entered into as of the Effective Date (as defined below), by and between Sagent Pharmaceuticals, Inc., a Delaware corporation (the Employer or the Company), and Allan Oberman, an individual (the Executive).
Sagent Pharmaceuticals Inc. – Sagent Pharmaceuticals, Inc. And Chengdu Kanghong Pharmaceuticals (Group) Co. Ltd Share Purchase Agreement Dated April 30, 2013 (May 6th, 2013)
CHENGDU KANGHONG PHARMACEUTICALS (GROUP) CO. LTD (the Selling Shareholder), a company duly incorporated and existing under the laws of Peoples Republic of China, having its business address at No. 36 Shuxi Road, Jinniu District, Chengdu City, Sichuan Province, China,
Sagent Pharmaceuticals Inc. – Share Pledge Agreement (May 6th, 2013)
This Share Pledge Agreement (hereinafter this Agreement) is dated April 30, 2013, and is entered into by and between CHENGDU KANGHONG PHARMACEUTICALS (GROUP) CO. LTD (the Pledgee), and SAGENT PHARMACEUTICALS, INC. (the Pledgor), a shareholder of KANGHONG SAGENT (CHENGDU) PHARMACEUTICAL CORPORATION LIMITED (KSCP).
Sagent Pharmaceuticals Inc. – Sagent Pharmaceuticals, Inc. Stockholders Agreement (April 26th, 2011)
This Stockholders Agreement (the Agreement) is made and entered into as of April 26, 2011, by and among Sagent Pharmaceuticals, Inc., a Delaware corporation (the Company), and each of the stockholders listed on Exhibit A attached hereto (collectively, the Investors).